The United States is the most costly healthcare system globally, spending about 17.9% of the GDP on health care, which is nearly 5% higher than the next highest spending country, with a projected increase of 5.5% per year towards USD$5.7 trillion by 2026. Uniformly, costs attributable to health care are rising and consuming a growing proportion of each developed country’s gross domestic product. In the second part of the value equation, namely cost, the aim is to best estimate costs in order to reform healthcare financing, which is complicated and can vary widely by country. This is the result of interpreting quality of care as compliance with evidence-based guidelines, which emphasized process measurement, rather than outcome measurement and their improvement. National Quality Measurement Clearinghouse, a registry of measurements from various quality reporting organizations, showed that only 7% of the measures were actually outcomes and less than 2% were patient-reported outcomes. However, even in 2016, outcome measurements were not measured as frequently as they should be at that time, an analysis of 1,958 measures from the U.S. feeling engaged in decision making), and quality of life. perceived diabetes control), patient experience (e.g. HbA1c was at goal less than 7% for a healthy adult less than 65 years old), patient-reported outcomes (e.g. Include health status, clinical measures (e.g. measurement of HbA1c every 3 months while actively managing medication doses for a patient with diabetes). having point-of-care hemoglobin A1c, or HbA1c, testing available in an outpatient clinic where patients seek management care for diabetes mellitus type 2). Refer to supporting structures that enable care provision (e.g. , first described in 1988, in which measures are classified in three categories: structures, processes, and outcomes. Types of measurement frequently follow a Donabedian approach Possibilities for measurements are virtually limitless, although in health care they have been derived traditionally from evidence-based clinical guidelines. Regarding the first part of the value equation, quality measurement is easier said than done. With greater effectiveness per unit of cost achieved, healthcare costs may still continue to rise, albeit at a slowed rate. By increasing value, patients primarily benefit as the central stakeholder, which thereby benefits healthcare providers, insurers, and healthcare systems in terms of effectiveness compared to costs. Optimizing outcomes that matter for patients means aligning medical and health care services, supportive services, process optimization efforts, health information technology, research and innovation. In its simplest definition, value is increased when there is more care quality for less cost. The primary aim overall is to crystallize a vision and direction towards true north in providing health care to patients, and set our collective sights on this goal. A seventh component was added to customize the agenda in certain contexts, for example, in the Netherlands, culture change and leadership are added to the agenda (Fig. The value agenda was originally developed in 2006 with six primary components, including measurement of outcomes and costs for every patient as the second step.
Is traditionally defined as health outcomes ( quality of care) achieved per dollar spent ( cost of care). Encompasses the overall vision for optimizing healthcare value for patients.
0 kommentar(er)
